In humans, the presence of the minor allele at the rs646776 variant of the 1p13 locus, which has an average frequency of ≈0. 212 (0.197-0.437), is associated with a 0.1 to 0.2 mmol/L Background-Elevated levels of lipids and lipoproteins have strong genetic determinants and are recognized as key risk factors for atherogenesis and cardiovascular disease, particularly in the postprandial state. The aim of the study to determine whether young adults, when stratified by genotype at the rs646776 variant of the 1p13 locus, displayed differential postprandial responses to an oral fat tolerance test. Methods and Results-Participants (n=30) received a high-fat mixed meal (91 g; 55% kcal from fat) after an overnight fast and a fat-exclusion meal (3.9 g; 6% kcal from fat) at 8 hours postprandially. 
C ardiovascular diseases (CVDs) remain the primary cause of morbidity and mortality worldwide. 1 In fact, many cardiovascular events occur in individuals who lack a high level of risk based on traditional single or multivariable risk scores, such as Framingham Risk Scores or the European Systematic Coronary Risk Evaluation. 2 On the basis of this evidence, it is apparent that other factors, such as genetics and unconventional biomarkers, contribute to this risk.
Clinical Perspective on p 582
A group of single nucleotide polymorphisms located at the 1p13 locus are consistently associated with CVD, myocardial infarction, coronary artery disease, and fasting lowdensity lipoprotein (LDL) cholesterol (LDL-C) based on genome-wide association studies. [3] [4] [5] [6] [7] [8] Of these, the rs646776 variant near the SORT1 gene is recognized as one of the most common, strongest LDL-C-associated single nucleotide polymorphisms, an association that persists even after lipid-lowering therapy. 4, 9 This noncoding variant creates a new CCAAT/enhancer-binding protein transcription factorbinding site that increases hepatic expression of sortilin, a multiligand sorting receptor, which localizes to the Golgi apparatus, with small amounts present in clathrin-coated pits on the cell membrane. 10, 11 Functional validation studies using humanized mouse models demonstrate that adenoassociated virus serotype 8-mediated hepatic sortilin overexpression increases LDL catabolism and decreases rate of very low-density lipoprotein (VLDL) secretion when compared with those injected with the null virus. 11 Given that VLDL is a precursor to LDL, these authors suggest a mechanism wherein sortilin serves a dual role in binding and trafficking extracellular LDL, and VLDL at the Golgi apparatus, to the lysosome for degradation, thus eliciting a phenotype characterized by decreased LDL-C as is observed in humans. lower fasting LDL-C level when compared with individuals who are homozygous for the major risk allele. 4, 9, 11, 13, 14 Clinically, this translates into a 9% to 13% decreased risk of CVD and 40% reduced risk of myocardial infarction in carriers of the minor allele. 15, 16 Despite this, variants at the SORT1 1p13 locus account for only 1% to 5% of the variation in fasting LDL-C levels, suggesting an element of residual CVD risk attributed to alternative factors. 17 We speculate that this may be partially attributed to the fact that associations between SORT1 and LDL-C have only been investigated in the fasting state. 3, 4, 11, 13, [17] [18] [19] On the basis of a Western-style eating pattern, we found that humans spend the majority of the time in the postprandial state; as such, the merits of using fasting levels to assess CVD risk and resting conditions are challenged. [20] [21] [22] Postprandial lipaemia is characterized by an influx of intestinally and hepatically derived triglyceride-rich lipoproteins, including VLDL, chylomicrons, and chylomicrons-remnants. [23] [24] [25] These particles are atherogenic in their own right, indicating that prolonged exposure to postprandial lipaemia is an important contributor to atherogenesis. 25, 26 Furthermore, accumulation of chylomicron particles coincides with VLDL production in the liver, exacerbating postprandial lipaemia. 27 The purpose of the present study was to investigate whether the presence of the minor allele (TC/CC) at the rs646776 single nucleotide polymorphism near the SORT1 gene was associated with postprandial lipid and lipoprotein responsiveness in healthy young adults, in whom the association of SORT1 is stronger when compared with that in older adults with diagnosed metabolic disease 4,28 because of fewer clinical confounding variables. 17, 18 Postprandial lipaemia was characterized using an oral fat tolerance test (OFTT) in combination with lipoprotein profiling via nuclear magnetic resonance (NMR) spectroscopy.
Materials and Methods

Participants
Subjects who completed the Assessing Inherited Markers of Metabolic Syndrome in the Young (AIMM Young) study at the University of Calgary 19 were recruited via email and invited to participate in the present OFTT study ( Figure I in the Data Supplement). At the time of this study, 197 individuals had completed the AIMM Young Study at the Calgary site, of whom 175 were recruited based on previous consent for recontact. Interested individuals were phone-screened to assess eligibility and included if they (1) had completed the initial AIMM Young testing protocol in its entirety, (2) were between the age groups of 18 and 35 years at the time of testing, (3) postpuberty, (4) were willing and able to provide informed consent, and (5) free of any dietary restrictions preventing test meal consumption. All participants were considered healthy at the time of testing, where health was defined as described previously. 19 Ethical approval for this study was granted by the University of Calgary Conjoint Health Research Ethics Board in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects before participation (Ethics ID 24813).
Anthropometric and Blood Pressure Measurements
Height and weight were measured using a calibrated balance beam scale. Body mass index was calculated by dividing weight (kilograms) by height squared (square meter). Percentage body fat was determined via dual energy x-ray absorptiometry (Hologic QDR 4500A scanner; Hologic Inc., Waltham, MA). Heart rate, systolic, and diastolic blood pressure were measured manually from the left arm, while the participant was seated.
Oral Fat Tolerance Test
After an overnight fast (8-12 hours), participants were given a highfat meal composed of 2 breakfast sandwiches, one hash-brown and orange juice from a major fast-food chain. The meal totaled 91 g of fat, 500 mg of cholesterol, and 1490 kcal. Fifty five percent, 32%, and 14% of the meal's energy content was attributed to fat, carbohydrates, and protein, respectively. Participants consumed the meal within 30 minutes; afterward, water was permitted ad libitum, no other food or beverages were consumed for the next 8 hours. Blood samples were obtained at fasting and 2, 4, 6, and 8 hours afterward, where t=0 was defined as meal initiation (Figure 1) . Immediately after the 8-hour blood draw, participants received a fat-exclusion meal, which contained 3.9-g fat, 0-mg cholesterol, and 603 kcal. Six percent, 84%, and 10% of the meal's energy content was attributed to fat, carbohydrates, and protein, respectively. Participants consumed this meal in its entirety, allowing for a second 8 to 12-hour fast before returning for a 24-hour blood draw. Participants remained sedentary for the entire 24-hour testing duration, in addition to prior 48 hours.
Blood Sample Collection and Handling
After collection, whole blood samples were rested for 30 minutes at room temperature. They were then centrifuged for 15 minutes at 3000 rpm at room temperature to separate the serum. A portion of serum was pipetted off and stored at −80°C for future analyses. Remaining samples were then refrigerated (2-8°C) and shipped to LipoScience (Raleigh, NC) via overnight courier. All samples were shipped using a unique identification number that did not disclose genotype.
Lipid and Lipoprotein Analysis
Fasting and postprandial blood samples were subject to comprehensive lipoprotein analysis using NMR spectroscopy (LipoScience). Lipoprotein subclass particle concentrations, including small LDL and large LDL; small high-density lipoprotein (HDL), medium HDL, and large HDL; intermediate-density lipoprotein (IDL); and small VLDL, medium VLDL, and large VLDL were determined using a 400-MHz NMR spectrometer (Bruker BioSpin Corporation, Billerica, MA) and proprietary analysis software (LipoScience). Weighted average VLDL, LDL, and HDL particle sizes, represented as diameter in nanometer, were calculated based on each subclass' relative mass percentage and intensity of the NMR signal. 29 Likewise, total triglyceride, VLDL-triglyceride, HDL-cholesterol, and total cholesterol levels were estimated from lipoprotein particle concentrations and established conversion factors, 29 which closely correlate to chemically derived values (r>0.9). 29 Finally, nephelometric apolipoprotein Participants arrived after an overnight fast (8-12 hours) and completed anthropometric and blood pressure measures. After a fasting blood draw, participants received a high-fat, mixed meal (M1, 91 g; 55% kcal from fat). Blood draws were taken via antecubital venipuncture at t=0, 2, 4, 6, and 8 hours. Immediately after the 8-hour blood draw, a fat exclusion meal (M2, 3.6 g; 6% kcal from fat) was provided. Participants returned the following morning, in the fasted state, for a final blood draw 24 hours after the test meal.
B immunoassays were used to determine the concentration of apolipoprotein B (AU680s Beckman Coulter, Brea, CA). The use of NMR spectroscopy for postprandial lipoprotein quantification has been reported previously.
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Diet Analysis
All participants submitted a 3-day dietary record completed during the course of 2 weekdays and 1 weekend-day before the test day. Three-day averages of macronutrient intake were determined using FoodWorks 14.0 software (The Nutrition Company, Long Valley, NJ).
Genotype Determination
Genotype at the rs646776 variant was accessed from previous testing as part of the AIMM Young study at the University of Calgary. 19 This variant was selected based on its relatively large effect size and abundance of lipid-associated phenotypes, 31 in addition to the strong association with LDL-C that we previously observed in this cohort. 19 No other variants were considered in the development, execution, or analysis of this study. Peripheral blood samples were collected in ethylene diamine tetra-ascetic acid anticoagulant tubes, which were stored at 2 to 8°C for a maximum of 1 week before analysis. Genotype at the rs646776 variant was determined using TaqMan allelic discrimination assay. 32 The Hardy-Weinberg equilibrium was calculated for this population previously and observed to be in concordance with the expected frequency. 19 For analyses, participants were stratified based on whether they were carriers of the minor, protective allele (TC/CC) or homozygous for the major, risk allele (TT), in accordance with previous reports of this variant. 3, 4, 11, 13, [17] [18] [19] 
Statistical Analysis
All statistical analyses were performed using SPSS Statistics, version 20 (IBM, Armonk, NY). All data are presented as mean±SEM. A list of SORT1-associated metabolites considered for analyses are shown in Table I in the Data Supplement. Total area under the curve (tAUC) and incremental area under the curve (iAUC) were calculated using the trapezoidal rule by Microsoft Excel 2007 and MATLAB 8.1, respectively. Given that tAUC is highly correlated with fasting concentration, 33 it was considered to be more reflective of overall exposure to a given variable, rather than postprandial changes. In contrast, iAUC is relatively independent from fasting concentration and thus regarded as a superior measurement of postprandial response. 33 Normality of distribution was tested by the Shapiro-Wilk test; non-normally distributed data were transformed accordingly. Comparisons were made via 2-way ANOVA, using sex and genotype at the rs646776 variant as fixed factors. The MannWhitney U test was used to determine differences in 8-hour iAUC between genotypes.
Results
Subject Characteristics
Thirty participants (mean age, 23.6 years; 15 men and 15 women) completed the OFTT study as outlined. The majority (80%) of participants were whites; remaining participants were Asian (16.7%) and Egyptian (3.3%). Men and women were equally stratified by genotype (TT, 8 men and 7 women; TC/CC, 7 men and 8 women) into 2 groups that displayed comparable subject characteristics with respect to biometric measures, fitness, total daily energy intake, and macronutrient intake (P>0.05; 
Fasting Lipoprotein Measures
Combined fasting VLDL and chylomicron particles concentrations were lower in carriers of the minor allele when Anthropometric and physiological characteristics were determined immediately before testing, with the exception of VO 2 peak and body fat, which were determined previously. Dietary characteristics were analyzed from 3-day dietary records completed during the course of 2 weekdays and 1 weekendday. Data are mean±SEM. No significant (P<0.05) differences for subject characteristics were observed between TT vs TC/CC. 
Postprandial Lipoprotein Measures
Overall, carriers of the minor allele exhibited an attenuated postprandial response when compared with TT homozygotes ( Figure 2B , 2E, and 2H). TC/CC genotypes displayed lower 4-hour tAUC (P=0.02; Figure 2C ), in addition to reduced mean concentration of combined VLDL and chylomicron particles for the entire 24-hour period (44.2±3.1 versus 57.0±4.5 nmol/L; P=0.03; Table IV 
Discussion
Objectives of the present study were to investigate whether genotype at the rs646776 variant of 1p13 locus is associated with differences in postprandial lipaemia in young adults. Major findings show that individuals heterozygous or homozygous for the minor, protective allele display (1) reduced fasting levels of combined VLDL and chylomicron particles, (2) decreased postprandial VLDL and chylomicron particles (combined), (3) decreased postprandial VLDL and chylomicron triglyceride content (combined) and total triglycerides, and (4) no differences in apolipoprotein B or LDL particle subclasses. Overall, carriers of the minor allele exhibited attenuated responses to the OFTT as seen in decreased exposure to atherogenic triglyceride-rich lipoproteins. Combined, these findings provide insight into the disparate risk for CVD and myocardial infarction in carriers of the minor, protective allele when compared with homozygotes for the major, risk allele.
The 1p13 locus gained attention after its initial identification and robust association with coronary artery disease, and later LDL-C, through genome-wide association studies. 15 Using comprehensive NMR profiling, we show an association between the minor, protective allele at the SORT1 1p13 locus and decreased VLDL particles in humans at fasting. This parallels previous findings, wherein the 1p13 locus was associated with NMR-derived total VLDL particles in a largescale genome-wide association study. 31 The presence of the minor allele at the 1p13 locus is associated with liver-specific increases in sortilin protein and SORT1 mRNA expression in humans. 11, 13 Our findings provide experimental evidence in humans in support of the mechanism of sortilin action proposed by Musunuru et al, 11 wherein sortilin overexpression in the livers decreases VLDL secretion through enhanced presecretory degradation.
Baseline reductions in VLDL and chylomicron particle numbers persisted into the postprandial state in carriers of the minor allele (TC/CC). These individuals exhibited attenuated tAUC and mean concentration during the duration of the study; however, no difference was observed in the iAUC when compared with TT homozygotes. Given that tAUC is highly dependent on fasting lipoprotein concentrations, these results suggest that the differences observed in the total exposure to VLDL and chylomicron particles postprandially are reflective of fasting values, rather than indicative of a unique response. Regardless, elevated fasting and postprandial circulating VLDL and chylomicron particles in major allele homozygotes are detrimental in their own right because they are associated with increased risk for type 2 diabetes mellitus, obesity, dyslipidemia, and progression of atherosclerotic plaques. 35 Reductions in VLDL and chylomicron particle number were also reflected in the triglyceride content of these particles because carriers of the minor allele exhibited a decreased postprandial response when compared with TT homozygotes. It was expected that elevations in VLDL and chylomicron triglyceride concentration would coincide with increased particle numbers, particularly because particle size was comparable between the 2 groups. Prolonged exposure to triglyceride-rich lipoproteins promotes triglyceride enrichment of LDL and HDL, which facilitates subsequent hydrolysis and production of small, dense LDL particles, which are recognized as the most detrimental of the LDL subclasses. 36, 37 Furthermore, the interlipoprotein exchange of lipids during the postprandial state is primarily propelled by endogenously synthesized VLDL particles secreted from the liver rather than intestinally derived chylomicron, providing further evidence points toward sortilin as a player in postprandial lipaemia. 38 We found that total triglycerides were lower in carriers of the minor allele genotypes relative to TT homozygotes. Unlike VLDL and chylomicron particles, these differences were not apparent at fasting, but at 2 hours postprandially, a time point that has been identified as a decisive predictor of future coronary artery disease risk. 39 Furthermore, carriers of the minor allele contrasted TT homozygotes because they had triglyceride concentrations that exceeded the National Cholesterol Education Plan Adult Treatment Panel III clinical fasting guidelines at the 2-and 4-hour time points. 34 Given that nonfasting triglyceride is recognized as a strong, independent risk factor for CVD, [40] [41] [42] carriers of the minor allele exhibited a less detrimental postprandial triglyceride response when compared with TT homozygotes. These findings may, in part, explain the disparate risk of CVD between carriers of the minor allele and TT homozygotes. Furthermore, these findings in addition to a novel association between SORT1 and triglycerides recently reported using a multiphenotype Bayesian strategy 43 may represent an additional role of the SORT1 gene in lipid metabolism.
No association between SORT1 and apolipoprotein B or LDL subclasses was observed at fasting or during the postprandial period. Because apolipoprotein B-100 is the major structural protein of VLDL and LDL, 44 we expected elevations in apolipoprotein B-100 to coincide with those observed in VLDL. Furthermore, these observations were surprising given SORT1's strong associations with LDL-C and total cholesterol. Most previous investigations have been founded on the Friedewald calculation, wherein LDL-C is calculated as a function of triglyceride concentration, which may provide insight into the results presented. 45 This highlights the value of NMR-based metabolomics analysis. 46, 47 Discrepant findings in LDL particles may also be attributed to the population studied because younger adults typically exhibit lower variance and fewer subjects with abnormal values, therefore potentially lowering the statistical power of the study. 17 Using an OFTT, we identified the genetic variant rs646776 in the 1p13 locus, a single nucleotide polymorphism that has been strongly associated with LDL-C, coronary artery disease, and myocardial infarction, [3] [4] [5] [6] [7] [8] to be a modifier of fasting lipid profile and postprandial lipaemia in fit, healthy young adults. These results provide further support for sortilin's role as a regulator of lipid metabolism. This strengthens its potential value as an identification tool for early screening programs and highlights the merits of future investigation into sortilin as a target for therapeutic intervention in an effort to alleviate the burden of CVD.
CLINICAL PERSPECTIVE
Cardiovascular diseases (CVD) are the leading cause of death and disability worldwide. Elevated concentrations of blood lipids have strong genetic determinants and are key risk factors for CVD. The rs646776 variant located near the SORT1 gene is of considerable interest because of its high minor allele frequency and large effect size, especially in younger populations. Carriers of the minor, protective allele exhibit decreased risk of CVD and myocardial infarction when compared with major allele homozygotes. Despite these strong associations, it accounts for only a fraction of variation in low-density lipoprotein cholesterol, an independent CVD risk factor, suggesting an element of residual risk attributed to alternative factors. One such factor is postprandial lipaemia, the change in blood lipid composition and concentration after meal ingestion. Although the SORT1-CVD relationship has been known for some time, this is the first study to investigate it in the context of postprandial lipaemia. We used an oral fat tolerance test in combination with nuclear magnetic resonance spectroscopy to demonstrate that young adults with the low-risk genotype near SORT1 exhibit attenuated postprandial lipaemia. Our results are novel in that we provide evidence of decreased exposure to atherogenic lipids and lipoproteins, suggesting relative protection against atherosclerosis and CVD when compared with homozygotes for the high-risk alleles. This supports a previously unexplored mechanistic link between SORT1 and postprandial lipaemia, highlighting this gene's role in lipid metabolism. Furthermore, our results strengthen its potential value, in combination with postprandial lipid profiles, as an identification tool for early screening programs to prevent CVD.
